Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Interest Expenses (2023 - 2025)

Immunocore Holdings' Interest Expenses history spans 3 years, with the latest figure at $3.1 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 56.62% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $12.2 million, down 35.44%, while the annual FY2025 figure was $12.2 million, 35.44% down from the prior year.
  • Interest Expenses for Q4 2025 was $3.1 million at Immunocore Holdings, roughly flat from $3.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $7.0 million in Q4 2024 and bottomed at $1.2 million in Q1 2023.
  • The 3-year median for Interest Expenses is $3.0 million (2025), against an average of $3.0 million.
  • The largest annual shift saw Interest Expenses skyrocketed 437.66% in 2024 before it plummeted 56.62% in 2025.
  • A 3-year view of Interest Expenses shows it stood at $1.3 million in 2023, then surged by 437.66% to $7.0 million in 2024, then tumbled by 56.62% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Interest Expenses are $3.1 million (Q4 2025), $3.0 million (Q3 2025), and $3.0 million (Q2 2025).